Skip to main content
Article thumbnail
Location of Repository

Anti-PlasmodiumActivity of Angiotensin II and Related Synthetic Peptides

By Ceres Maciel, Vani Xavier de Oliveira Junior, Marcos Antonio Fazio, Rafael Nacif Pimenta, Antonio Miranda, Paulo Filemon Paolucci Pimenta and Margareth Lara Capurro

Abstract

Plasmodiumspecies are the causative agents of malaria, the most devastating insect-borne parasite of human populations. Finding and developing new drugs for malaria treatment and prevention is the goal of much research. Angiotensins I and II (ang I and ang II) and six synthetic related peptides designated Vaniceres 1-6 (VC1-VC6) were assayedin vivo andin vitro for their effects on the development of the avian parasite,Plasmodium gallinaceum.Ang II and VC5 injected into the thoraces of the insects reduced mean intensities of infection in the mosquito salivary glands by 88% and 76%, respectively. Although the mechanism(s) of action is not completely understood, we have demonstrated that these peptides disrupt selectively the P.gallinaceumcell membrane. Additionally, incubation in vitro of sporozoites with VC5 reduced the infectivity of the parasites to their vertebrate host. VC5 has no observable agonist effects on vertebrates, and this makes it a promising drug for malaria prevention and chemotherapy

Topics: Malaria, Plasmodium
Year: 2008
OAI identifier: oai:agregador.ibict.br.RI_FIOCRUZ:oai:localhost:icict/6661
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.rcaap.pt/detail.jsp... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.